Different activation of TRAF4 and TRAF6 in inflammatory bowel disease

Mediators of Inflammation

Volumn 2013, Issue , 2013, Pages

  Shen, Jun ^a   Qiao, Yuqi ^a   Ran, Zhihua ^a   Wang, Tianrong ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 4; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6; TRAF4 PROTEIN, HUMAN;

ADULT; ARTICLE; CLINICAL ARTICLE; COLITIS; CONTROLLED STUDY; DISEASE ACTIVITY; ENTERITIS; FEMALE; GENE EXPRESSION; HUMAN; MALE; PANCOLITIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REMISSION; UPREGULATION; BLOOD; CROHN DISEASE; METABOLISM; MIDDLE AGED; MONONUCLEAR CELL; ULCERATIVE COLITIS;

ADULT; COLITIS, ULCERATIVE; CROHN DISEASE; FEMALE; HUMANS; INFLAMMATORY BOWEL DISEASES; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; TNF RECEPTOR-ASSOCIATED FACTOR 4; TNF RECEPTOR-ASSOCIATED FACTOR 6;

EID: 84874525738     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2013/647936     Document Type: Article

References (28)

1. Chung J. Y., Lu M., Yin Q., Lin S. C., Wu H., Molecular basis for the unique specificity of TRAF6. Advances in Experimental Medicine and Biology 2007 597 122 130 2-s2.0-34547766563 10.1007/978-0-387-70630-6-10
2. Tseng P. H., Matsuzawa A., Zhang W., Mino T., Vignali D. A. A., Karin M., Different modes of ubiquitination of the adaptor TRAF3 selectively activate the expression of type i interferons and proinflammatory cytokines. Nature Immunology 2010 11 1 70 75 2-s2.0-74049136127 10.1038/ni.1819
3. Jalukar S. V., Hostager B. S., Bishop G. A., Characterization of the roles of TNF receptor-associated factor 6 in CD40-mediated B lymphocyte effector functions. The Journal of Immunology 2000 164 2 623 630 2-s2.0-0034650867 (Pubitemid 30043681)
4. Baccam M., Bishop G. A., Membrane-bound CD154, but not CD40-specific antibody, mediates NF-kappaB-independent IL-6 production in B cells. European Journal of Immunology 1999 29 3855 3866
5. Akiyama T., Maeda S., Yamane S., Ogino K., Kasai M., Kajiura F., Matsumoto M., Inoue J. I., Dependence of self-tolerance on TRAF6-directed development of thymic stroma. Science 2005 308 5719 248 251 2-s2.0-16444377660 10.1126/science.1105677 (Pubitemid 40558859)
6. Esparza E. M., Arch R. H., TRAF4 functions as an intermediate of GITR-induced NF- B activation. Cellular and Molecular Life Sciences 2004 61 24 3087 3092 2-s2.0-12144283407 10.1007/s00018-004-4417-0 (Pubitemid 40104583)
7. Kalkan T., Iwasaki Y., Chong Y. P., Thomsen G. H., Tumor necrosis factor-receptor-associated factor-4 is a positive regulator of transforming growth factor- β signaling that affects neural crest formation. Molecular Biology of the Cell 2009 20 14 3436 3450 2-s2.0-67749120312 10.1091/mbc.E08-03- 0325
8. Wei S. C., Rosenberg I. M., Cao Z., Huett A. S., Xavier R. J., Podolsky D. K., Tribbles 2 (Trib2) is a novel regulator of toll-like receptor 5 signaling. Inflammatory Bowel Diseases 2012 18 877 888
9. Feagins L. A., Role of transforming growth factor- β in inflammatory bowel disease and colitis-associated colon cancer. Inflammatory Bowel Diseases 2010 16 11 1963 1968 2-s2.0-78249231410 10.1002/ibd.21281
10. Blanco-Kelly F., Matesanz F., Alcina A., Teruel M., Díaz-Gallo L. M., Gómez-García M., López-Nevot M. A., Rodrigo L., Nieto A., Cardeña C., Alcain G., Díaz-Rubio M., de la Concha E. G., Fernandez O., Arroyo R., Martín J., Urcelay E., CD40: novel association with crohn's disease and replication in multiple sclerosis susceptibility. PLoS ONE 2010 5 7 2-s2.0-77955384911 10.1371/journal.pone.0011520 e11520
11. Zepp J. A., Liu C., Qian W., Wu L., Gulen M. F., Kang Z., Li X., Cutting edge: TNF receptor-associated factor 4 restricts IL-17-mediated pathology and signaling processes. The Journal of Immunology 2012 189 33 37
12. Livak K. J., Schmittgen T. D., Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method. Methods 2001 25 4 402 408 2-s2.0-0035710746 10.1006/meth.2001.1262 (Pubitemid 34164012)
13. McWhirter S. M., Pullen S. S., Holton J. M., Crute J. J., Kehry M. R., Alber T., Crystallographic analysis of CD40 recognition and signaling by human TRAF2. Proceedings of the National Academy of Sciences of the United States of America 1999 96 15 8408 8413 2-s2.0-0033587691 10.1073/pnas.96.15.8408 (Pubitemid 29354804)
14. Ni C. Z., Welsh K., Leo E., Chiou C. K., Wu H., Reed J. C., Ely K. R., Molecular basis for CD40 signaling mediated by TRAF3. Proceedings of the National Academy of Sciences of the United States of America 2000 97 19 10395 10399 2-s2.0-0034641743
15. Qu F., Gao H., Zhu S., Shi P., Zhang Y., Liu Y., Jallal B., Yao Y., Shi Y., Qian Y., TRAF6-dependent Act1 phosphorylation by the I B kinase-related kinases suppresses interleukin-17-induced NF- B activation. Molecular and Cellular Biology 2012 32 3925 3937
16. Schreiber S., Nikolaus S., Hampe J., Activation of nuclear factor B inflammatory bowel disease. Gut 1998 42 4 477 484 2-s2.0-0031925362 (Pubitemid 28186562)
17. Mukundan L., Bishop G. A., Head K. Z., Zhang L., Wahl L. M., Suttles J., TNF receptor-associated factor 6 is an essential mediator of CD40-activated proinflammatory pathways in monocytes and macrophages. The Journal of Immunology 2005 174 2 1081 1090 2-s2.0-11844290745 (Pubitemid 40094305)
18. Carey R., Jurickova I., Ballard E., Bonkowski E., Han X., Xu H., Denson L. A., Activation of an IL-6:STAT3-dependent transcriptome in pediatric-onset inflammatory bowel disease. Inflammatory Bowel Diseases 2008 14 4 446 457 2-s2.0-42449133751 10.1002/ibd.20342 (Pubitemid 351571824)
19. Kobayashi T., Walsh P. T., Walsh M. C., Speirs K. M., Chiffoleau E., King C. G., Hancock W. W., Caamano J. H., Hunter C. A., Scott P., Turka L. A., Choi Y., TRAF6 is a critical factor for dendritic cell maturation and development. Immunity 2003 19 3 353 363 2-s2.0-0141678952 10.1016/S1074-7613(03)00230-9 (Pubitemid 37153412)
20. Davies C. C., Mak T. W., Young L. S., Eliopoulos A. G., TRAF6 is required for TRAF2-dependent CD40 signal transduction in nonhemopoietic cells. Molecular and Cellular Biology 2005 25 22 9806 9819 2-s2.0-27644531924 10.1128/MCB.25.22.9806-9819.2005 (Pubitemid 41572731)
21. Rowland S. L., Tremblay M. M., Ellison J. M., Stunz L. L., Bishop G. A., Hostager B. S., A novel mechanism for TNFR-associated factor 6-dependent CD40 signaling. The Journal of Immunology 2007 179 7 4645 4653 2-s2.0-44749092679
22. Scaldaferri F., Sans M., Vetrano S., Correale C., Arena V., Pagano N., Rando G., Romeo F., Potenza A. E., Repici A., Malesci A., Danese S., The role of MAPK in governing lymphocyte adhesion to and migration across the microvasculature in inflammatory bowel disease. European Journal of Immunology 2009 39 1 290 300 2-s2.0-60549114409 10.1002/eji.200838316
23. Lappalainen M., Paavola-Sakki P., Halme L., Turunen U., Heliö T., Färkkilä M., Kontula K., Screening of tumor necrosis factor receptor-associated factor 6 as a candidate gene for inflammatory bowel disease. Scandinavian Journal of Gastroenterology 2006 41 4 424 429 2-s2.0-33646429208 10.1080/00365520500265166 (Pubitemid 43675408)
24. Cherfils-Vicini J., Vingert B., Varin A., Tartour E., Fridman W. H., Sautès-Fridman C., Régnier C. H., Cremer I., Characterization of immune functions in TRAF4-deficient mice. Immunology 2008 124 4 562 574 2-s2.0-46949111507 10.1111/j.1365-2567.2008.02810.x (Pubitemid 351962552)
25. Kedinger V., Rio M. C., TRAF4, the unique family member. Advances in Experimental Medicine and Biology 2007 597 60 71 2-s2.0-34547803242 10.1007/978-0-387-70630-6-5
26. Kalkan T., Iwasaki Y., Chong Y. P., Thomsen G. H., Tumor necrosis factor-receptor-associated factor-4 is a positive regulator of transforming growth factor- β signaling that affects neural crest formation. Molecular Biology of the Cell 2009 20 14 3436 3450 2-s2.0-67749120312 10.1091/mbc.E08-03- 0325
27. Stadnicki A., Machnik G., Klimacka-Nawrot E., Wolanska-Karut A., Labuzek K., Transforming growth factor- β 1 and its receptors in patients with ulcerative colitis. International Immunopharmacology 2009 9 6 761 766 2-s2.0-67349222177 10.1016/j.intimp.2009.02.014
28. Craxton A., Shu G., Graves J. D., Saklatvala J., Krebs E. G., Clark E. A., p38 MAPK is required for CD40-induced gene expression and proliferation in B lymphocytes. The Journal of Immunology 1998 161 7 3225 3236 2-s2.0-0032193226